This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Treating Onychomychosis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2008 by Nomir Medical Technologies.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Nomir Medical Technologies
ClinicalTrials.gov Identifier:
NCT00776464
First received: October 18, 2008
Last updated: October 20, 2008
Last verified: October 2008
  Purpose
A study to treat 4 toes at a time to eliminate Onychomycosis

Condition Intervention Phase
Onychomycosis Device: Noveon laser Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Further study details as provided by Nomir Medical Technologies:

Primary Outcome Measures:
  • Complete or near complete disappearance of toenail fungus [ Time Frame: 360 days ]

Estimated Enrollment: 60
Study Start Date: November 2008
Estimated Study Completion Date: January 2010
Estimated Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Noveon laser
    Two wavelenghts of light
  Eligibility

Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years or older
  • positive onychomycosis
  • negative pregnancy

Exclusion Criteria:

  • peripheral neuropathy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00776464

Contacts
Contact: Alan Robbins, MD 781-893-1000 alanhrobbins@comcast.com

Locations
United States, Massachusetts
Nomir Medical Not yet recruiting
Waltham, Massachusetts, United States, 02452
Contact: Alan robbins, MD    781-893-1000    alanrobbins@comcast.com   
Sponsors and Collaborators
Nomir Medical Technologies
  More Information

Responsible Party: nomir medical, Nomir Medical Technologies
ClinicalTrials.gov Identifier: NCT00776464     History of Changes
Other Study ID Numbers: #10-001
Study First Received: October 18, 2008
Last Updated: October 20, 2008

Additional relevant MeSH terms:
Onychomycosis
Tinea
Dermatomycoses
Skin Diseases, Infectious
Infection
Mycoses
Nail Diseases
Skin Diseases

ClinicalTrials.gov processed this record on September 21, 2017